Surgical Resection versus Open-Approach Radiofrequency Ablation for Small Hepatocellular Carcinomas within Milan Criteria after Successful Transcatheter Arterial Chemoembolization

Journal of Gastrointestinal Surgery

Volumn 17, Issue 10, 2013, Pages 1752-1759

  Lei, Jianyong ^a   Wang, Wentao ^a   Yan, Lunan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Complication; Downstage; Milan Criteria; Radiofrequency Ablation; Resection

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; CATHETERIZATION; CHEMOEMBOLIZATION; COMPARATIVE STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REMISSION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CATHETERIZATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84884670689     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2311-5     Document Type: Article

References (41)

1. Bosh FX, Ribes J, Borras J. Epidemiology of primary of liver cancer. Semin Liver Dis 1999;19: 271-85.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2): 69-90.
3. Willatt JM, Francis IR, Novelli PM, Vellody R, Pandya A, Krishnamurthy VN. Interventional therapies for hepatocellular carcinoma. Cancer Imaging. 2012 Apr 5; 12: 79-88.
4. Colombo M, De Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Eng J Med 1991;325: 675.
5. Cance WG, Stewart AK, Menck HR. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas improved survival of surgically resected patients, 1985-1996. Cancer. 2000;88(4): 912-20.
6. Lei JY, Yan LN. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful down-staging therapies. J Gastrointest Surg. 2012. 16(11): 2120-2125.
7. Herrero JI, Sangro B, Pardo F, et al. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 2008;14: 272-278.
8. Yao FY, Kinkhabwala M, LaBerge JM, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005;5(Pt 1): 795-804.
9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42: 1208-1236.
10. Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M, Ercolani G, et al. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transpl 2008;8: 2547-2557.
11. Chapman WC, Doyle MB, Stuart JE, Vachharajani N, Crippin JF, Anderson CD, et al. Outcomes of neoadjuvant transarterail chemoembolization to down-stage hepatocellular carcinoma before liver transplantation. Ann Surg 2008;248: 617-625.
12. Yamasaki S, Hasegawa H, Makuuchi M, et al. Choice of treatment for small hepatocellular carcinoma: hepatectomy, embolization or ethanol injection. J Gastroenterol Hepatol 1991;6: 408-13.
13. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosisL is resection still the treatment of choice? Hepatoloy 2008;47: 82-9.
14. Shiina S, Teratani T, Obi S et al. A randomized controlled trail of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129: 122-30.
15. Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010;51: 1284-90.
16. Majno PE, Mentha G, Mazzaferro V. Paritial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: confirming the trail that will never be, and some comments on the indications for liver resection. Hepatology 2010;51: 1116-18.
17. Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC confirming to the Milan criteria. Ann Surg. 2010 Dec;252(6): 903-12.
18. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trail comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243: 321-8.
19. Yao FY, Kerlan RK Jr, Hirose R, Davern TJ 3rd, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep;48(3): 819-27.
20. Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, Peri E, Ravaioli M, Pinna AD, Bolindi L. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5cm) hepatocellular carcinomas. Hepatology. 2011 May;53(5): 1580-9. [PMID: 21351114 doi: 10. 1002/hep. 24246].
21. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30: 52-60.
22. Edeline J, Boucher E, Rolland Y et al. Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma. Cancer. 2012;118: 147-156.
23. Eguchi S, Kanematsu T, Arii S, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatoectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008;143: 469-75.
24. Yun WK, Choi MS, Choi D, et al. Superior long-term outcomes after surgery in Child-Pugh class A patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 2010;5: 722-729.
25. Huang J, Hernadez-Alejandro R, Croome KP, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Child A cirrhotics-a retrospective study of 1061 cases. J Gastrointest Surg 2011;15: 311-20.
26. Guo WY, Zhai B, Lai EC, et al. Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocelluar carcinomas: a nonrandomized comparative study. World J Surg 2010;34: 2671-6.
27. Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellula carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005;39: 247-52.
28. Wakai T, Shirai Y, Suda T, et al. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or-4 cm. World J Gastroenterol 2006;12: 546-52.
29. Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology. 2012 Mar;262(3): 1022-33.
30. Chan AC, Poon RT, Cheung TT, Chik KS, Chan SC, Fan ST, Lo CM. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocelluar carcinoma. World J Surg. 2012 Jan;36(1): 151-6.
31. Abu-Hilai M, Primrose JN, Casaril A, et al. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg. 2008;12: 1521-6.
32. Montorsi M, Santambrogio R, Bianchi P, et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocelular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg. 2005;9: 62-7.
33. Millonig G, Graziadei IW, Freund MC, et al. Response to preoperative chemoembolization correlates with hepatocellular carcinoma. Liver Transpl 2007;13: 272-279.
34. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226: 688-701.
35. Lo CM, Fan ST, Liu CL, et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg. 2007;94: 78-86.
36. Giannelli G, Antonaci S. Novel concepts in hepatocellular carcinoma: from molecular research to clinical practice. J Clin Gastroenterol. 2006 Oct; 40(9): 842-6.
37. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Sur 2009;249(4): 617-623.
38. Teratani T, Toshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so called high risk locations. Hepatology. 2006;43: 1101-8.
39. Kornrizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97: 1253-62.
40. Hon T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38: 977-81.
41. Ueno S, Sakoda M, Kubo F, et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas with Milan criteria. J Hepatobiliary Pancreat Surg. 2009;16(3): 359-66.